PortfoliosLab logo
1177.HK vs. 6078.HK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between 1177.HK and 6078.HK is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

1177.HK vs. 6078.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sino Biopharmaceutical Ltd (1177.HK) and Hygeia Healthcare Holdings Co Ltd (6078.HK). The values are adjusted to include any dividend payments, if applicable.

-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-71.21%
-43.90%
1177.HK
6078.HK

Key characteristics

Sharpe Ratio

1177.HK:

1.13

6078.HK:

-0.76

Sortino Ratio

1177.HK:

1.65

6078.HK:

-1.02

Omega Ratio

1177.HK:

1.22

6078.HK:

0.88

Calmar Ratio

1177.HK:

0.52

6078.HK:

-0.59

Martin Ratio

1177.HK:

2.91

6078.HK:

-1.04

Ulcer Index

1177.HK:

15.61%

6078.HK:

50.40%

Daily Std Dev

1177.HK:

38.98%

6078.HK:

69.73%

Max Drawdown

1177.HK:

-87.72%

6078.HK:

-88.42%

Current Drawdown

1177.HK:

-79.16%

6078.HK:

-86.52%

Fundamentals

Market Cap

1177.HK:

HK$69.07B

6078.HK:

HK$9.02B

EPS

1177.HK:

HK$0.00

6078.HK:

HK$0.00

PE Ratio

1177.HK:

35.09

6078.HK:

14.44

PS Ratio

1177.HK:

2.39

6078.HK:

2.03

PB Ratio

1177.HK:

2.02

6078.HK:

1.27

Returns By Period

In the year-to-date period, 1177.HK achieves a 20.81% return, which is significantly higher than 6078.HK's 1.54% return.


1177.HK

YTD

20.81%

1M

9.58%

6M

10.20%

1Y

48.18%

5Y*

-18.21%

10Y*

-7.83%

6078.HK

YTD

1.54%

1M

3.42%

6M

-15.29%

1Y

-53.54%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

1177.HK vs. 6078.HK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

1177.HK
The Risk-Adjusted Performance Rank of 1177.HK is 8080
Overall Rank
The Sharpe Ratio Rank of 1177.HK is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of 1177.HK is 8181
Sortino Ratio Rank
The Omega Ratio Rank of 1177.HK is 8080
Omega Ratio Rank
The Calmar Ratio Rank of 1177.HK is 7474
Calmar Ratio Rank
The Martin Ratio Rank of 1177.HK is 7979
Martin Ratio Rank

6078.HK
The Risk-Adjusted Performance Rank of 6078.HK is 1616
Overall Rank
The Sharpe Ratio Rank of 6078.HK is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of 6078.HK is 1212
Sortino Ratio Rank
The Omega Ratio Rank of 6078.HK is 1515
Omega Ratio Rank
The Calmar Ratio Rank of 6078.HK is 1414
Calmar Ratio Rank
The Martin Ratio Rank of 6078.HK is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

1177.HK vs. 6078.HK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and Hygeia Healthcare Holdings Co Ltd (6078.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for 1177.HK, currently valued at 1.17, compared to the broader market-2.00-1.000.001.002.003.00
1177.HK: 1.17
6078.HK: -0.75
The chart of Sortino ratio for 1177.HK, currently valued at 1.69, compared to the broader market-6.00-4.00-2.000.002.004.00
1177.HK: 1.69
6078.HK: -1.00
The chart of Omega ratio for 1177.HK, currently valued at 1.22, compared to the broader market0.501.001.502.00
1177.HK: 1.22
6078.HK: 0.88
The chart of Calmar ratio for 1177.HK, currently valued at 0.56, compared to the broader market0.001.002.003.004.005.00
1177.HK: 0.56
6078.HK: -0.59
The chart of Martin ratio for 1177.HK, currently valued at 2.99, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
1177.HK: 2.99
6078.HK: -1.03

The current 1177.HK Sharpe Ratio is 1.13, which is higher than the 6078.HK Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of 1177.HK and 6078.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
1.17
-0.75
1177.HK
6078.HK

Dividends

1177.HK vs. 6078.HK - Dividend Comparison

1177.HK's dividend yield for the trailing twelve months is around 1.54%, while 6078.HK has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
1177.HK
Sino Biopharmaceutical Ltd
1.54%1.86%2.31%2.19%0.73%0.71%0.37%0.77%0.22%0.49%0.25%0.27%
6078.HK
Hygeia Healthcare Holdings Co Ltd
0.00%0.00%0.46%0.00%0.30%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

1177.HK vs. 6078.HK - Drawdown Comparison

The maximum 1177.HK drawdown since its inception was -87.72%, roughly equal to the maximum 6078.HK drawdown of -88.42%. Use the drawdown chart below to compare losses from any high point for 1177.HK and 6078.HK. For additional features, visit the drawdowns tool.


-90.00%-85.00%-80.00%-75.00%NovemberDecember2025FebruaryMarchApril
-72.42%
-86.51%
1177.HK
6078.HK

Volatility

1177.HK vs. 6078.HK - Volatility Comparison

The current volatility for Sino Biopharmaceutical Ltd (1177.HK) is 18.61%, while Hygeia Healthcare Holdings Co Ltd (6078.HK) has a volatility of 23.51%. This indicates that 1177.HK experiences smaller price fluctuations and is considered to be less risky than 6078.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%NovemberDecember2025FebruaryMarchApril
18.61%
23.51%
1177.HK
6078.HK

Financials

1177.HK vs. 6078.HK - Financials Comparison

This section allows you to compare key financial metrics between Sino Biopharmaceutical Ltd and Hygeia Healthcare Holdings Co Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in HKD except per share items